Our Study Impact through the Decades
| MACS began 1984 • | WIHS began 1993 • | MWCCS began 2019 |
| HIV Outcomes • Early HIV Medicine | Cancer • Early HIV Medicine • HIV Pathogenesis | Aging and Multimorbidity • Diabetes and Adiposity • Mental Health and Stigma • Cardiovascular • Liver • HIV Outcomes • Social Determinants of Health/Health Disparaties | Mental Health and Stigma • Aging and Multimorbidity • Cardiovascular • Liver • Sex Hormones and Bone Health | Aging and Multimorbidity • Sex Hormones and Bone Health • Cancer • Diabetes and Adiposity • Pulmonary |
MWCCS Publications 2019 - 2025
MWCCS 2025 Publications by Topic Area (N=91)
CVD: Cardiovascular Disease
HPV: Human Papillomavirus
STI: Sexually Transmitted Infection
NOW AVAILABLE:
Data on Key Intensive Measurements for 1000s of Participants
CLICK FOR MORE INFORMATION >MWCCS as a Platform
MACS & WIHS Publications:
Papers Characterizing Our Cohort
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants
Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr.
The Women’s Interagency HIV Study. WIHS Collaborative Study Group
Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J and Grp, WIHS Collaborative Study
Characteristics Of The MACS-WIHS Combined Cohort Study: Opportunities For Research On Aging With Hiv In The...
D'Souza G, Bhondoekhan F, Benning L, Margolick JB, Adedimeji AA, Adimora AA, Alcaide ML, Cohen MH, Detels R, Friedman MR, Holman S, Konkle-Parker DJ, Merenstein D, Ofotokun I, Palella F, Altekruse S, Brown TT, Tien PC
Psychosocial aspects of AIDS risk
Ostrow, D.G., Joseph, J., Monjan, A., Kessler, R., Emmons, C., Phair, J., Fox, R., Kingsley, L., Dudley, J., Chmiel, J.S. and Van Raden, M.
The Changing Science of HIV Epidemiology in the United States
Gypsyamber D'Souza, Elizabeth T Golub, Stephen J Gange
Work from our Early Stage Investigators
NIH defines an Early Stage Investigator (ESI) as a Program Director / Principal Investigator (PD/PI) who has completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who has not previously competed successfully as a PD/PI for a substantial NIH independent research award.
